Levetiracetam for the treatment of neonatal seizures

Journal of Child Neurology

Volumn 22, Issue 1, 2007, Pages 95-98

  Shoemaker, Michael T ^a   Rotenberg, Joshua S ^a  

^a WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

Levitiracetam; Neonate; Seizure

Indexed keywords

ETIRACETAM; FOSPHENYTOIN SODIUM; MIDAZOLAM; OXCARBAZEPINE; PHENOBARBITAL;

ABSENCE OF SIDE EFFECTS; ARTICLE; BRAIN INFARCTION; BRAIN VENTRICLE PERITONEUM SHUNT; CASE REPORT; CHILD CARE; COMPUTER ASSISTED TOMOGRAPHY; DRUG APPROVAL; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; FEMALE; FOCAL EPILEPSY; HUMAN; HYDROCEPHALUS; INFANT; LOW BIRTH WEIGHT; LUMBAR PUNCTURE; MALE; NEWBORN INTENSIVE CARE; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRESCRIPTION; PRIORITY JOURNAL; SEIZURE; TONIC CLONIC SEIZURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANTICONVULSANTS; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PIRACETAM; SEIZURES;

EID: 34249852186     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073807299973     Document Type: Article

References (18)

1. Bello-Espinosa LE, Roberts SL Levitiracetam for benign epilepsy of childhood with centrotemporal spikes-three cases. Seizure. 2003; 12: 157-159.
2. Tan MJ, Appleton RE Efficacy and tolerability of levetiracetam in children aged 10 years and younger: A clinical experience. Seizure. 2004; 13: 142-145.
3. Glauser TA, Pellock JM, Bebin EM, et al. Efficacy and safety of levetiracetam in children with partial seizures: An open-label trial. Epilepsia. 2002; 43: 518-524.
4. Mizrahi E. Neonatal seizures and neonatal epileptic syndromes. Neurol Clin. 2001; 19: 427-463.
5. Zupanc ML Neonatal seizures. Pediatr Clin North Am. 2004; 51: 961-978.
6. Volpe JJ Neurology of the Newborn. 4th ed. Philadelphia, Pa: WB Saunders; 2001.
7. Hahn CD, Riviello JJ Neonatal seizures and EEG: Electroclinical dissociation and uncoupling. Neoreviews. 2004; 5: E350-e355.
8. Sankar R., Holmes GL Mechanisms of action for the commonly used antiepileptic drugs: Relevance to antiepileptic drug-associated neurobehavior adverse effects. J Child Neurol. 2004; 19 (suppl 1): S6-S14.
9. Klitgaard H. Levetiracetam: The preclinical profile of a new class of antiepileptic drugs? Epilepsia. 2001; 42 (suppl 4): 13-18.
10. French JA, Kanner AM, Bautista J., et al. Efficacy and tolerability of the new antiepileptic drugsR II: Treatment of refactory epilepsy: report of the TTA and Qss Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. 2004; 45: 410-423.
11. Koukkari MW, Guarino EJ Retrospective study of the use of levetiracetam in childhood seizure disorders. J Child Neurol. 2004; 19: 944-947.
12. Lagae L., Buyse G., Deconinck A., et al. Effect of levetiracetam in refractory childhood epilepsy syndromes. Eur J Paediatr Neurol. 2003; 7: 123-128.
13. Lagae L., Buyse G., Ceulemans B. Clinical experience with levetiracetam in childhood epilepsy: An add-on and mono-therapy trial. Seizure. 2005; 14: 66-71.
14. Wheless JW, Ng Y. Levetiracetam in refractory pediatric epilepsy. J Child Neurol. 2002; 17: 413-415.
15. Herranz JL, Rufo-Campos M., Arteaga R. Effectiveness and tolerability of levetiracetam in 43 children and adolescents with epilepsy. Rev Neurol. 2003; 37: 1005-1008.
16. Grosso S., Franzoni E., Coppola G., et al. Efficacy and safety of levetiracetam: An add-on trial in children with refractory epilepsy. Seizure. 2005; 14: 248-253.
17. Coppola G., Mangano S., Tortorella G., et al. Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy. Epilepsy Res. 2004; 59: 35-42.
18. Johannessen SI, Helde G., Brodtkorb E. Levetiracetam concentrations in serum and in breast milk at birth and during lactation. Epilepsia. 2005; 46: 775-777.